Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph‐node density
Open Access
- 16 January 2009
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 103 (3), 302-306
- https://doi.org/10.1111/j.1464-410x.2008.07988.x
Abstract
OBJECTIVE To determine the risk factors associated with clinical outcome in patients with lymph node (LN)‐positive urothelial carcinoma of the upper urinary tract (UTUC) treated with radical nephroureterectomy (RNU) and lymphadenectomy, focusing on the concept of LN density (LND). PATIENTS AND METHODS Patients undergoing RNU with regional lymphadenectomy were identified through multi‐institutional databases. All pathology slides were re‐evaluated by genitourinary pathologists unaware of the clinical data. The exposure variable used was LND (continuously coded and that of all possible thresholds) with recurrence‐free and disease‐specific survival (DSS) serving as the outcome measures. RESULTS Of 432 patients undergoing RNU with lymphadenectomy, 135 (31%) had LN metastases. Within a median follow‐up of 4.1 years, 90 of the 135 patients with LN metastases (68%) had disease recurrence and 76 (58%) died from UTUC. The mean (sem) 5‐year recurrence‐free and DSS probabilities were 27 (4)% and 33 (5)%, respectively. The median (range) LND was 50 (3–100)%. The most informative threshold for LND in relation to outcome was 30%. In multivariable analyses that adjusted for the effects of tumour stage and grade, patients with a LND of ≥30% were at greater risk of both cancer recurrence, with 5‐year rates of 25 (5)% vs 38 (8)% (hazard ratio 1.8, P = 0.021) and mortality, with 5‐year rates of 30 (6)% vs 48 (9)% (1.7, P = 0.032) compared to those with a LND of <30%. Our results are primarily limited by a lack of standardization in the lymphadenectomy template. CONCLUSION We evaluated the concept of LND for the first time in UTUC. LND provides additional prognostic information in patients with node‐positive disease after RNU. The use of LND in clinical trials might provide an additional insight into the value of LN dissection in patients undergoing RNU.Keywords
This publication has 22 references indexed in Scilit:
- Urothelial Carcinoma of the Upper Urinary Tract: Surgical Approach and Prognostic FactorsEuropean Urology, 2008
- Prognostic Value of Lymph Node Dissection in Patients with Muscle-Invasive Transitional Cell Carcinoma of the Upper Urinary TractEuropean Urology, 2008
- Independent predictors of cancer‐specific survival in transitional cell carcinoma of the upper urinary tractCancer, 2007
- Radical Cystectomy With Extended Lymphadenectomy: Evaluating Separate Package Versus en Bloc Submission for Node Positive Bladder CancerJournal of Urology, 2007
- Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancerInternational Journal of Urology, 2006
- Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research ConsortiumJournal of Urology, 2006
- EAU Guidelines on Diagnosis and Treatment of Upper Urinary Tract Transitional Cell CarcinomaEuropean Urology, 2004
- Risk Factors for Patients With Pelvic Lymph Node Metastases Following Radical Cystectomy With En Bloc Pelvic Lymphadenectomy: The Concept of Lymph Node DensityJournal of Urology, 2003
- IMPACT OF THE NUMBER OF LYMPH NODES RETRIEVED ON OUTCOME IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCERJournal of Urology, 2002
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994